AbbVie Invests $380M to Expand Illinois Manufacturing for Neuroscience, Obesity Meds
Insurance Journal - Feb 24, 2026
AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus, expanding its domestic production capacity for its neuroscience and obesity medicines. The investment is part of AbbVie’s broader …...
Recommended Articles
Posted: Mar 02, 2026
Michigan Attorney General Dana Nessel has reached a settlement with Holloo Farms, a concentrated ani...
Posted: Mar 02, 2026
Zurich Insurance Group announced it has agreed with UK specialty insurer Beazley the terms of an all...
Posted: Mar 02, 2026
Independent wholesale specialty insurance distributor CRC Group said it has completed its acquisitio...